Methods for Improving Cognitive Function and Decreasing Heart Rate
AssigneeDsm IP Assets B.V.
InventorKarin YURKO-MAURO
Life of this patent
Estimating the term…
Abstract
The present invention is directed to methods of improving cognitive function in subjects having age related cognitive decline or mild cognitive impairment and to methods of decreasing heart rate in a subject by administering dosage forms comprising docosahexaenoic acid (DHA) substantially free of eicosapentaenoic acid (EPA).
Claims35
A method of treating age related cognitive decline (ARCD) or mild cognitive impairment (MCI), comprising administering to a subject in need thereof about 0.8 g to about 4 g of docosahexaenoic acid (DHA) per day in a dosage form substantially free of eicosapentaenoic acid (EPA) and substantially free of arachidonic acid (ARA).
2-7. (canceled)
9-11. (canceled)
(canceled)
15-16. (canceled)
18-19. (canceled)
21-40. (canceled)
42-47. (canceled)
49-54. (canceled)
A method of reducing heart rate, comprising administering docosahexaenoic acid to a subject in need thereof about 0.8 g to about 4 g of docosahexaenoic acid (DHA) per day in a dosage form substantially free of eicosapentaenoic acid (EPA) and substantially free of arachidonic acid (ARA).
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.